个体患者荟萃分析:白蛋白尿变化与GFR急性变化的关联
该个体患者荟萃分析纳入49项随机对照试验、66,449例参与者,评估慢性肾脏病进展治疗初期GFR(基线至3个月)与白蛋白尿(基线至6个月)早期变化的关系。结果显示,试验水平上治疗对GFR与白蛋白尿的效应无关联,个体水平上两臂均见相似关联,提示早期变化可能反映疾病自然史而非治疗效应。
要点
- 试验水平上,治疗对早期GFR变化与白蛋白尿变化的效应无关联(斜率0.00,95% BCI -0.08至0.09)。
- 个体水平上,治疗臂和对照臂中GFR下降与白蛋白尿下降均呈相似关联。
- 除外免疫抑制研究,其他干预类别中均观察到个体水平关联。
核心结论
- 个体患者在治疗臂和对照臂中GFR变化与白蛋白尿变化关联相似。
- 试验水平上治疗对GFR和白蛋白尿的效应无关联。
- 早期GFR和白蛋白尿变化可能更多反映疾病自然史或其他因素,而非治疗效应。
研究设计与样本
- 个体患者荟萃分析,纳入49项随机对照试验、66,449例符合条件的参与者。
- 估算基线至3个月的早期GFR变化和基线至6个月的白蛋白尿变化。
- 采用贝叶斯混合效应荟萃回归分析试验水平关联,采用调整线性回归分析个体水平关联。
主要发现
- 试验水平:荟萃回归斜率0.00(95% BCI -0.08至0.09),R2 0.03(95% BCI 0.03至0.27)。
- 个体水平:GFR每多下降一个标准差,治疗臂白蛋白/肌酐比值几何均值下降8.0%(7.1%至8.9%),对照臂下降6.6%(5.6%至7.6%)。
- 除免疫抑制研究外,各干预类别中均见个体水平关联;免疫抑制研究中两臂均未观察到该关联。
临床怎么用
- 解读早期GFR和白蛋白尿变化作为疗效标志时需谨慎,因其可能反映疾病自然史。
- 个体患者中GFR下降与白蛋白尿下降的关联在治疗和对照臂相似,不宜单独归因于治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Early changes in albuminuria and glomerular filtration rate (GFR) have been proposed as markers of treatment efficacy for individual patients. Here, we evaluated the relationship between changes in GFR and in albuminuria in the immediate period after initiation of medication across trials and within individual patients. METHODS: In 49 randomized controlled trials encompassing 66,449 eligible participants, we estimated early changes in GFR from baseline to 3 months and in albuminuria from baseline to 6 months. We first used Bayesian mixed-effects meta-regression to relate treatment effects on early GFR change (acute effects) with treatment effects on albuminuria across trials. Second, we examined associations between an individual's change in GFR and albuminuria using adjusted linear regression in both treatment and control arms. RESULTS: There was no evidence of association between mean treatment effects on GFR and albuminuria across studies (meta-regression slope 0.00 [95% Bayesian credible intervals, BCI, -0.08, 0.09], R2 0.03 [95% BCI, 0.03, 0.27]). For individual patients, a similar magnitude of associations between changes in albuminuria and GFR were observed in both arms: for each standard deviation greater decline in GFR, the geometric mean albumin/creatinine ratio declined by 8.0% (7.1%, 8.9%) in participants in the treatment arm and by 6.6% (5.6%, 7.6%) in those in the control arm. The effect was seen in each of the intervention classes except for the immunosuppressive studies, where this association was not observed within either the intervention or control arms. CONCLUSIONS: There were similar associations between changes in GFR and albuminuria for individual patients in both treatment and control arms and no association between the treatment effects on GFR and albuminuria at the trial level. This suggests that early changes in GFR and albuminuria may be more likely related to the natural history of the disease or other factors, rather than the effect of treatments.
引用
- Inker LA, Heerspink HJL, Tighiouart H, et al. An individual patient meta-analysis assessed the associations between change in albuminuria and acute changes in the glomerular filtration rate in randomized controlled trials of chronic kidney disease progression. Kidney Int. 2026. PMID: 42815853. doi:10.1016/j.kint.2026.08.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。